- Home
- GLP vs BCRX Comparison
GLP vs BCRX Comparison
Compare GLP & BCRX Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- GLP
- BCRX
- Stock Information
- Founded
- GLP 2005
- BCRX 1986
- Country
- GLP United States
- BCRX United States
- Employees
- GLP N/A
- BCRX N/A
- Industry
- GLP Oil Refining/Marketing
- BCRX Biotechnology: Biological Products (No Diagnostic Substances)
- Sector
- GLP Energy
- BCRX Health Care
- Exchange
- GLP Nasdaq
- BCRX Nasdaq
- Market Cap
- GLP 1.8B
- BCRX 1.9B
- IPO Year
- GLP 2005
- BCRX 1994
- Fundamental
- Price
- GLP $50.68
- BCRX $8.40
- Analyst Decision
- GLP Hold
- BCRX Strong Buy
- Analyst Count
- GLP 1
- BCRX 10
- Target Price
- GLP $56.00
- BCRX $16.70
- AVG Volume (30 Days)
- GLP 34.0K
- BCRX 3.6M
- Earning Date
- GLP 08-07-2025
- BCRX 08-04-2025
- Dividend Yield
- GLP 6.02%
- BCRX N/A
- EPS Growth
- GLP N/A
- BCRX N/A
- EPS
- GLP 2.60
- BCRX N/A
- Revenue
- GLP $17,827,598,000.00
- BCRX $557,506,000.00
- Revenue This Year
- GLP $38.58
- BCRX $37.96
- Revenue Next Year
- GLP $17.34
- BCRX $8.82
- P/E Ratio
- GLP $19.60
- BCRX N/A
- Revenue Growth
- GLP 3.74
- BCRX 45.85
- 52 Week Low
- GLP $37.00
- BCRX $6.02
- 52 Week High
- GLP $60.00
- BCRX $11.31
- Technical
- Relative Strength Index (RSI)
- GLP 46.30
- BCRX 46.54
- Support Level
- GLP $48.72
- BCRX $8.08
- Resistance Level
- GLP $51.42
- BCRX $8.64
- Average True Range (ATR)
- GLP 1.46
- BCRX 0.32
- MACD
- GLP -0.07
- BCRX 0.06
- Stochastic Oscillator
- GLP 47.28
- BCRX 42.68
About GLP Global Partners LP Common Units representing Limited Partner Interests
Global Partners LP is a limited partnership that acts as a midstream logistics and marketing company. It is mainly engaged in purchasing, selling, storing and logistics of transporting petroleum and related products. The company owns and operates and control terminal networks of refined petroleum products and renewable fuels in Massachusetts, Maine, Connecticut, Vermont, and other places. It distributes gasoline and gasoline blendstocks, distillates, residual oil, renewable fuels, crude oil, natural gas and propane to wholesalers, retailers and commercial customers. The company operates through three segments i.e. Wholesale, Gasoline Distribution and Station Operations and Commercial. It generates maximum revenue from the Wholesale segment.
About BCRX BioCryst Pharmaceuticals Inc.
BioCryst Pharmaceuticals Inc is a biotechnology company involved mainly in the research and development of novel small-molecule drugs, to block key enzymes involved in infectious and inflammatory diseases. Biocryst's research is based on multiple scientific disciplines like biology, computer modeling, and medicinal chemistry. Its products and candidates target the following therapeutic areas: acute uncomplicated influenza; uncomplicated seasonal influenza; hereditary angioedema; filoviruses, including the Ebola and Marburg viruses; and oncology.